CClinicalTrials.gg
Not yet recruitingNCT07437677ULIFT-PDUpdated Feb 27, 2026

A Survey for Patients and Caregivers Aiming to Understand and Improve the Care of Patients at High Risk of Transfer From Peritoneal Dialysis to Hemodialysis:

An observational study in Peritoneal Dialysis (PD), Hemodialysis and Kidney Replacement Therapy, sponsored by Ciusss de L'Est de l'Île de Montréal. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-27.

Sponsored by Ciusss de L'Est de l'Île de Montréal · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
200
Ages
18 Years and older
Sex
All
01

Study summary

Home dialysis is encouraged in Canada and peritoneal dialysis is the most common home dialysis method. However, many patients discontinue peritoneal dialysis, often transferring to hemodialysis. Despite the frequency of this transition, little is known about its impact on patients.

Overall, the UPLIFT-PD program aims to fill this gap by studying the transition from peritoneal dialysis to hemodialysis. The specific goal of this mixed methods sub-study is to conduct a national survey to ask patients and caregivers about priorities and preferences when they anticipate a transfer from peritoneal dialysis to hemodialysis. This survey will be co-created by patient-partners and dialysis experts.

Results from this survey will then be used in other phases of UPLIFT-PD program, detailed in other registrations, which will support people facing a transition from peritoneal dialysis to hemodialysis..

02

Conditions studied

  • Peritoneal Dialysis (PD)
  • Hemodialysis
  • Kidney Replacement Therapy
  • Transition

Keywords

  • Transfer to hemodialysis
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Adult patients with lived experience of peritoneal dialysis and transitions to hemodialysis, as well as caregivers of such patients, recruited from dialysis centers and patient communities across multiple centers.

Inclusion criteria

  1. Adult (≥18 years)
  2. One of the following:

    • Patient who experienced a PD-to-HD transition in past 12 months
    • Patient currently receiving peritoneal dialysis
    • Caregiver (self-defined, including spouses, family members, or friends) of individuals meeting the above criteria
  3. Able to read English or French
  4. Able to complete the survey in paper or web-based format
  5. Able to provide informed consent

Exclusion criteria

Exclusion Criteria:

  • Age \<18 years
  • Unable to provide consent
04

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No

Groups and cohorts

  • Survey Participants

    Survey participants will include both patients (or their caregivers) having experienced a transition to hemodialysis in the past year or currently receiving peritoneal dialysis

05

What researchers measure

Primary outcomes

  1. Priorities and Challenges Related to PD-to-HD Transitions

    Measured using Likert-scale responses assessing perceived importance of transition-related factors (e.g. preparedness, timing of discussions, vascular access planning, psychosocial impact). Likert-scale from 0 (lowest importance) to 9 (highest importance)

    Time frame: At survey completion (Baseline)

Secondary outcomes

  1. Preferences for Clinical Scenarios Related to PD-to-HD Transitions

    Assessed using a discrete choice experiment evaluating trade-offs between attributes such as duration on PD, risk of complications, and planned vs. unplanned HD transfer.

    Time frame: At survey completion (Baseline)

  2. Perceptions of Successful Transition

    Agreement with proposed definitions of successful PD-to-HD transitions based on care pathways.

    Time frame: At survey completion (Baseline)

Other outcomes

  1. Qualitative Themes Related to Transition Experiences

    Analysis of open-ended responses to identity key themes and concepts.

    Time frame: At survey completion (Baseline)

06

Study locations

No study locations are listed for this record.

07

References and documents

Individual participant data

Plan to share: No — Considering the survey nature of the study and in compliance with our ethic board requirements

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07437677
Lead sponsor
Ciusss de L'Est de l'Île de Montréal
Collaborators
Canadian Institutes of Health Research (CIHR)
Responsible party
Annie-Claire Nadeau-Fredette (Nephrologist, Clinical Scientist, Ciusss de L'Est de l'Île de Montréal) — Principal investigator
First posted
Feb 27, 2026
Start date
Jan 2027 (estimated)
Primary completion
Dec 2027 (estimated)
Completion
Dec 2029 (estimated)
Last update
Feb 27, 2026

Study contacts

Annie-Claire Nadeau-Fredette, MD MSc
Contact
ac.nadeau-fredette@umontreal.ca
514-252-3400 ext. 6141
Émilie Robitaille
Contact
emilie.robitaille.cemtl@ssss.gouv.qc.ca
514-252-3400 ext. 5289
Annie-Claire Nadeau-Fredette, MD MSc
principal investigator · CIUSSS de l'Est-de-l'Ile de Montréal

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion